Phani Sekhar Of Angel Broking is of the view that one can hold IndusInd Bank and one can even accumulate the stock on 5-10 percent correction.
Sekhar told CNBC-TV18, " IndusInd Bank with the recent dilution of Rs 2000 crore resulting in 11 percent dilution, they have positioned themselves beautifully for the next three years to sustain credit growth at around 25 percent asset quality among the new age private sector banks is among the best. Net interest margins after moderating to 3.2 percent will likely inch up and stabilize at around 3.5 percent in a declining interest rate environment. So, everything is going right for them." .
Jitendra Panda, Future Capital is of the view that one can buy Tata Motors with a target of Rs 324.
Panda told CNBC-TV18, " Tata Motors is looking very positive and today also we are seeing long positions and at this level I would recommend for January long positions. Keep stop loss around Rs 305 and look at a target of Rs 324 because January is a new calendar year for autos and the numbers could be good there. In December month the way positives are getting build, we believe numbers are getting much positive, fundamentals will get set in for the January new calendar year when the auto companies generally do well. We believe Tata Motors is well placed to move to Rs 324 levels."
Emkay Global Financial Services is bullish on Gitanjali Gems (GGL) and has recommended buy rating on the stock with a target price of Rs 742 in its December 19, 2012 research report.
"GGL's transition from a low margin diamond processor to a jewellery manufacturer and retailer has borne fruit, with high value jewellery segment constituting 56% of revenues. This mix change has transformed GGL's financial profile by driving revenues, improving margins and bringing stability to its business model.
Omkar Speciality Chemicals Private Limited was incorporated on February 24, 2005 and took over business of the Proprietorship Firm M/s. Omkar Chemicals which was in operation since 1983 with capacity of 6 MT per annum for manufacture of molybdenum derivatives. The Private Limited Company was converted into a Public Limited Company on March 18, 2010. The Company is mainly engaged in the manufacture and sale of Speciality Chemicals and Intermediates for Chemical and Allied Industries.
DISCLAIMER: GoodReturns provides you with information covering shares, futures and options based on broker's reports as stated on various media. Investors are, however, warned that they should NOT take any buy or sell decision based on these views expressed in the article. Investors should consult their own financial and share advisors before taking purchase or sale decisions. GoodReturns does not take any responsibility for any losses incurred by investors who take their cues from the above article.